163 related articles for article (PubMed ID: 28882010)
21. [The Spanish Society of Paediatric Infectious Diseases (SEIP) recommendations on the diagnosis and management of invasive candidiasis].
Figueras C; Díaz de Heredia C; García JJ; Navarro M; Ruiz-Contreras J; Rossich R; Rumbao J; Frick MA; Roselló EM;
An Pediatr (Barc); 2011 May; 74(5):337.e1-337.e17. PubMed ID: 21396895
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of candidaemia and invasive candidiasis. A changing face.
Quindós G
Rev Iberoam Micol; 2014; 31(1):42-8. PubMed ID: 24270071
[TBL] [Abstract][Full Text] [Related]
23. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
24. Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility.
Nieto MC; Tellería O; Cisterna R
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):34-40. PubMed ID: 25439581
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China.
Pu S; Niu S; Zhang C; Xu X; Qin M; Huang S; Zhang L
J Microbiol Immunol Infect; 2017 Feb; 50(1):97-103. PubMed ID: 25769664
[TBL] [Abstract][Full Text] [Related]
26. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
[TBL] [Abstract][Full Text] [Related]
27. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
Shorr AF; Wu C; Kothari S
J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
[TBL] [Abstract][Full Text] [Related]
28. Development of New Strategies for Echinocandins: Progress in Translational Research.
Walsh TJ; Azie N; Andes DR
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S601-3. PubMed ID: 26567276
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy.
Lichtenstern C; Nguyen TH; Schemmer P; Hoppe-Tichy T; Weigand MA
Mycoses; 2008; 51 Suppl 1():35-46. PubMed ID: 18471160
[TBL] [Abstract][Full Text] [Related]
30. Non-albicans Candida infections in patients with hematologic malignancies.
Moosa MY; Sobel JD
Semin Respir Infect; 2002 Jun; 17(2):91-8. PubMed ID: 12070827
[TBL] [Abstract][Full Text] [Related]
31. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
32. [Echinocandins and the 2009 guidelines for treatment of candidiasis].
Melo LH
Drugs Today (Barc); 2010 Mar; 46 Suppl B():7-12. PubMed ID: 20407663
[TBL] [Abstract][Full Text] [Related]
33. [Update on invasive candidiasis in non-neutropenic critically ill adult patients].
Zaragoza R; Ramírez P; Borges M; Pemán J
Rev Iberoam Micol; 2016; 33(3):145-51. PubMed ID: 27395022
[TBL] [Abstract][Full Text] [Related]
34. Caspofungin for the treatment of candidaemia in patients with haematological malignancies.
Pagano L; Fianchi L; Fanci R; Candoni A; Caira M; Posteraro B; Morselli M; Valentini CG; Farina G; Mitra ME; Offidani M; Sanguinetti M; Tosti ME; Nosari A; Leone G; Viale P
Clin Microbiol Infect; 2010 Mar; 16(3):298-301. PubMed ID: 19549221
[TBL] [Abstract][Full Text] [Related]
35. Candida tropicalis in human disease.
Chai LY; Denning DW; Warn P
Crit Rev Microbiol; 2010 Nov; 36(4):282-98. PubMed ID: 20883082
[TBL] [Abstract][Full Text] [Related]
36. Austrian clinical practice with anidulafungin in 2008: a multicenter survey.
Perkhofer S; Hell M; Gustorff B; Von Goedecke A; Illievich U; Kratzer C; Moosbauer W; Wimmer P; Zerlauth U; Nachbaur K; Vogel W; Bellmann R; Schwameis F; Lass-Flörl C
J Chemother; 2011 Oct; 23(5):285-9. PubMed ID: 22005061
[TBL] [Abstract][Full Text] [Related]
37. Rapid development of Candida krusei echinocandin resistance during caspofungin therapy.
Forastiero A; Garcia-Gil V; Rivero-Menendez O; Garcia-Rubio R; Monteiro MC; Alastruey-Izquierdo A; Jordan R; Agorio I; Mellado E
Antimicrob Agents Chemother; 2015 Nov; 59(11):6975-82. PubMed ID: 26324281
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of Invasive Candidiasis in Patients with Hematologic Malignancy on Antifungal Prophylaxis.
McCort ME; Tsai H
Mycopathologia; 2023 Dec; 188(6):885-892. PubMed ID: 37314582
[TBL] [Abstract][Full Text] [Related]
39. Impact of a multifaceted educational intervention including serious games to improve the management of invasive candidiasis in critically ill patients.
Ferrer R; Zaragoza R; Llinares P; Maseda E; Rodríguez A; Quindós G;
Med Intensiva; 2017; 41(1):3-11. PubMed ID: 27645566
[TBL] [Abstract][Full Text] [Related]
40. Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium.
Tiraboschi IN; Bennett JE; Kauffman CA; Rex JH; Girmenia C; Sobel JD; Menichetti F
Med Mycol; 2000; 38 Suppl 1():199-204. PubMed ID: 11204146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
